StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'
September 1, 2026 1:27 PM
Needham analyst Michael Matson reiterated a Buy rating and $114.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst comments "MDT's ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Medtronic, Inc. (MDT) PT Raised to $100 at BTIG
September 1, 2026 12:50 PM
Increasing unusual call volume: GPRO DPRO DUST FRVO CRK TENB EIX DKS VYX MDT BMEA
September 1, 2026 10:20 AM
TD Cowen on Medtronic, Inc. (MDT): 'We believe the results should be enough to sustain recent multiple expansion'
September 1, 2026 8:05 AM
Medtronic jumps on earnings beat and raised guidance
September 1, 2026 7:33 AM
Form 8-K Medtronic plc For: Sep 01
September 1, 2026 6:47 AM
Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
September 1, 2026 6:47 AM
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
September 1, 2026 6:45 AM
Medtronic invests $700M in Cornerstone Robotics partnership
September 1, 2026 6:40 AM
Medtronic Announces Strategic Partnership with Cornerstone Robotics to Further Expand Global Access to Robotic-Assisted Surgery
September 1, 2026 6:40 AM
Medtronic invests up to $80M in Pi-Cardia, eyes acquisition
September 1, 2026 6:30 AM
Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR
September 1, 2026 6:30 AM
Medtronic (MDT) call put ratio 1.4 calls to 1 put into quarter results
August 31, 2026 10:39 AM
Medtronic, Inc. (MDT) PT Raised to $110 at TD Cowen
August 28, 2026 5:09 AM
